MURATA-MANUFACTURING
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) unveils a significant advancement in the realm of electronic components with the launch of its innovative L Cancel Transformer (LCT). This remarkable product is the first of its kind and can neutralize the equivalent series inductance (ESL) of a capacitor, optimizing its noise-reducing capabilities. Utilizing Murata’s exclusive ceramic multilayer technology, this breakthrough solution allows engineers to reduce system noise while decreasing costs and component count.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240513693449/en/
[Murata Manufacturing Co., Ltd.] L Cancel Transformer(Photo: Business Wire)
As the demand for miniaturized and highly functional electronics increases, the issue of electromagnetic noise is becoming increasingly prominent for many industries. As a noise countermeasure, capacitors are often utilized between the power supply line and ground, but this method is not without its challenges. The noise removal effectiveness of the capacitor is optimal when a capacitor’s impedance is lowest. However, capacitor impedance can rise due to its ESL, particularly at frequencies beyond the self-resonant frequency, undermining the efficacy of the noise cancellation. To minimize this impact, it is common practice to connect numerous capacitors in parallel in order to collectively reduce impedance, at the expense of Bill of Material (BoM) component count and costs.
Murata’s LCT is a revolutionary new concept capable of resolving the longstanding challenge of managing power supply noise and capacitor component count. Murata’s LCT component is specifically engineered to minimize noise within the frequency range of a few MHz to 1GHz. It achieves this by utilizing negative mutual inductance to reduce a noise-reducing capacitor’s ESL and therefore increase the effectiveness of its operation, drastically reducing the number of required capacitors.
By using non-magnetic ceramic multilayer technology in its construction, the LCT ensures stable negative inductance and low DC resistance (maximum 55mΩ) even in the presence of current variations and is suitable for a wide range of applications, including consumer, industrial and healthcare products. Murata’s LCT breakthrough is a result of their extensive multilayer ceramic knowledge and redefines power supply noise reduction circuit design, and minimizes a significant and persistent electronic design challenge.
Each LCT is suitable for temperatures up to temperatures 125oC and since there is no DC superposition characteristic, it can be used with stable negative inductance up to 3A. The surface mount device (SMD) measures just 2.0 x 1.25 x 0.95 mm and is available in tape and reel packing.
“Murata’s new LCT is a true innovation that does not merely improve what is available, but redefines what is seen as a standard noise suppression component by radically redefining the entire concept”, said Masamichi Ando, Vice President Business Incubation Center Corporate Technology & Business Development Unit, at Murata. “With this revolutionary component, engineers will be able to reduce component count, system complexity and costs, helping to both further miniaturize their solutions and reduce its impact on the environment by lowering material consumption.”
Murata’s LCT (Part number: LXLC21HN0N9C0L) is entering production with samples available now. For more information please visit here.
Please contact us for details: contact form
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513693449/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HTEC Momentum Recognized as a Clutch Global Honoree and Champion for Fall 20259.12.2025 17:09:00 CET | Press release
HTEC Momentum (formerly Momentum Design Lab), HTEC’s research, product design, management and innovation arm, has earned two of Clutch’s highest distinctions—Global Award honoree and Clutch Champion—reaffirming its ninth straight year as the platform’s top-rated UX agency worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209358771/en/ HTEC Momentum Recognized as a Clutch Global Honoree and Champion for Fall 2025 The Clutch Global Awards honorees are selected based on demonstrated industry expertise and exceptional delivery—evaluated through thousands of verified client reviews published on Clutch. Clutch’s rigorous, case-study-driven review process includes extensive verification to ensure the authenticity and depth of each submission. These distinctions further underscore HTEC Momentum’s position as a top-rated leader in UX strategy, design, and user research, reflecting the consistent satisfaction of our clients
Onego Bio Launches “The Power of Trichoderma reesei” Series to Showcase Innovation, Scale, and Real-World Applications9.12.2025 17:00:00 CET | Press release
Onego Bio, a food ingredient company producing non-animal egg protein with precision fermentation*, today announced the launch of a new expert series titled “The Power of Trichoderma reesei: Building the Future with Fungi.” This multi-part initiative reveals the full potential of Trichoderma reesei, the microbial platform behind Onego’s Bioalbumen®, by spotlighting its scientific strengths, industrial scale, and practical performance across food manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209632524/en/ Headshot of Dr. Sharief Barends The first session, “Why Trichoderma reesei is Precision Fermentation’s Quiet Workhorse,” will be held on December 18, 2025, featuring Dr. Sharief Barends, Head of Research Leiden (Netherlands) and Head of Fungal Genetics at IFF, and Dr. Christopher Landowski, Co-Founder and Chief Technology Officer at Onego Bio. Together, they will explore the research legacy, strengths, and
Guinea Emerges as West Africa's New Digital Transformation Powerhouse9.12.2025 16:53:00 CET | Press release
The Republic of Guinea has reached a decisive turning point as a regional digital power. By hosting the Transform Africa Summit 2025, becoming the first francophone nation to receive this major continental event since its creation in 2013, Guinea confirmed the emergence of Conakry as a new digital innovation hub in West Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209780892/en/ Rose Pola Pricemou, Minister of Posts, Telecommunications and Digital Economy of the Republic of Guinea (Photo: AETOSWire) The numbers break all records: over 7,000 participants from 79 countries, including 47 ministers, 1,552 government representatives, 584 business leaders, over 590 start-ups, and 14 MoUs signed. Never before in the history of the Transform Africa Summit has such mobilisation been accomplished. This unprecedented turnout demonstrates international confidence in Guinea's ability to lead Africa's digital transformation ch
Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions9.12.2025 16:47:00 CET | Press release
The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. Rapid Medical™, a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a multicenter randomized study assessing the TIGERTRIEVER 13™ device in patients with distal medium vessel occlusions (DMVO) in acute ischemic stroke. “DMVO strokes represent up to 40% of ischemic strokes and can cause significant disability, yet their treatment has remained uncertain. Recent neutral results from ESCAPE-MEVO and DISTAL made one thing clear: distal thrombectomy requires devices and trials specifically engineered for distal vessels,” said Dr. Jeffrey Saver of UCLA in California, Principal Investigator of DISTALS. “TIGER 13 and DISTALS bring that dedicated design. Completing enrollment is a major step toward evidence that can truly advance care for these patients.
Suzano Launches Nature Strategy and Reinforces the Strategic Importance of Biodiversity Conservation to the Business9.12.2025 16:41:00 CET | Press release
This initiative brings together science and stakeholder collaboration to drive solutions to biodiversity challenges at scale Suzano, the world’s largest pulp producer, has launched its Nature Strategy, reaffirming the company's commitment to biodiversity and how it guides decision-making within the business. Suzano's operations depend directly on nature, and the company recognizes that its longevity and ability to innovate are intrinsically linked to the health of ecosystems. Therefore, nature occupies a significant strategic role in the business’ vision. The science-led Nature Strategy, developed in collaboration with IUCN, is guided by the mitigation hierarchy: avoid, reduce, restore and transform. This approach enables the prevention of impacts, the minimization of risks, and the promotion of ecosystem regeneration. With support from IUCN, Suzano has pioneered the use of the STAR metric – a tool that enables the company to map sensitive areas within the territories where it operates
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
